ABUS vs MAA · P/E 5.4, rev $6.2M vs P/E 31, $18.07B cap
Arbutus Biopharma Corp (ABUS) versus Mid-America Apartment Communities Inc (MAA) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
Mid-America Apartment Communities Inc (MAA) is a reit - residential company listed on US.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
MAA does not have a complete income-statement cache yet.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. MAA currently screens at market cap $18.07B and trailing P/E 31.2.
Not investment advice. Open the ABUS and MAA stock pages for the full models.
Not investment advice.